N-(5,6-Bis((4-(2-fluorobenzyl)piperazin-1-yl)methyl)-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)octanamide

ID: ALA4788342

PubChem CID: 152264085

Max Phase: Preclinical

Molecular Formula: C38H50F2N8O2

Molecular Weight: 688.87

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4F)CC3)c(CN3CCN(Cc4ccccc4F)CC3)c2c(=O)[nH]1

Standard InChI:  InChI=1S/C38H50F2N8O2/c1-2-3-4-5-6-15-34(49)42-38-43-36-35(37(50)44-38)30(26-47-20-16-45(17-21-47)24-28-11-7-9-13-31(28)39)33(41-36)27-48-22-18-46(19-23-48)25-29-12-8-10-14-32(29)40/h7-14H,2-6,15-27H2,1H3,(H3,41,42,43,44,49,50)

Standard InChI Key:  WHYBLXOLASEUMC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 50 55  0  0  0  0  0  0  0  0999 V2000
    9.4554  -25.7384    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9433  -25.0755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4621  -24.4079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6754  -25.4778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6820  -24.6586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9765  -24.2472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2639  -24.6497    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2612  -25.4719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9673  -25.8838    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9821  -23.4259    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5482  -25.8826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8417  -25.4678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1286  -25.8784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8441  -24.6464    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4180  -25.4636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7050  -25.8742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9943  -25.4594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2813  -25.8701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5707  -25.4553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8576  -25.8659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7172  -23.6274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5212  -23.4601    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7804  -22.6797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0701  -24.0734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5844  -22.5124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8742  -23.9020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1292  -23.1215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7605  -25.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1655  -25.7893    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9827  -25.7934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7534  -26.4950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3878  -26.5031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9757  -27.2088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1585  -27.2047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9290  -22.9536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4743  -23.5622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3808  -27.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1979  -27.9226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2192  -24.3355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7637  -24.9438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5644  -24.7762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8177  -23.9948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2715  -23.3898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6010  -28.6325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4174  -28.6369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8304  -27.9307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4209  -27.2186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6058  -27.2177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5221  -22.6120    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.1980  -26.5096    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  1  2  1  0
  2  3  2  0
  3  5  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  6 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  3 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  1  0
 24 26  1  0
 25 27  1  0
 26 27  1  0
  2 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
 30 32  1  0
 31 34  1  0
 32 33  1  0
 33 34  1  0
 27 35  1  0
 35 36  1  0
 33 37  1  0
 37 38  1  0
 36 39  2  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 36  1  0
 38 44  2  0
 44 45  1  0
 45 46  2  0
 46 47  1  0
 47 48  2  0
 48 38  1  0
 43 49  1  0
 48 50  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4788342

    ---

Associated Targets(Human)

FGFR4 Tclin Fibroblast growth factor receptor 4 (3668 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TEK Tclin Tyrosine-protein kinase TIE-2 (3348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 688.87Molecular Weight (Monoisotopic): 688.4025AlogP: 5.46#Rotatable Bonds: 15
Polar Surface Area: 103.60Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.87CX Basic pKa: 7.02CX LogP: 5.75CX LogD: 5.57
Aromatic Rings: 4Heavy Atoms: 50QED Weighted: 0.14Np Likeness Score: -0.80

References

1. Lee JH,El-Damasy AK,Seo SH,Gadhe CG,Pae AN,Jeong N,Hong SS,Keum G.  (2018)  Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: Synthesis, cell based assays, kinase profile and molecular docking study.,  26  (21): [PMID:30385226] [10.1016/j.bmc.2018.10.004]

Source